Unilever Outlines Strategy Behind $68 Billion GSK Consumer Health Care Bid

The company has so far had three bids rejected as it aims to extend its offer in health, beauty and hygiene

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

Unilever has outlined why it has tabled three bids, with the latest at around $68 billion, for the Consumer Healthcare division of GlaxoSmithKline (GSK). Following an “extensive” review, the British owner of Ben & Jerry’s, PG Tips, Dove and Lipton Tea has decided that its strategic direction should be to “materially expand” its health, beauty and hygiene offer.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in